Mathilde Horn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mathilde Horn has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Guillaume Vaiva
Univ. Lille, INSERM U1172, CHU Lille, Centre Lille Neuroscience & Cognition (INTERACTIONS), F-59000 Lille, France; CHU Lille, Pôle de Psychiatrie, F-59000 Lille, France; Centre National de Ressources et de Résilience Lille-Paris (CN2R), Lille F-59000, France
11 shared publicationsAli Amad
Univ. Lille, INSERM U1172, CHU Lille, Centre Lille Neuroscience & Cognition (INTERACTIONS), F-59000 Lille, France; CHU Lille, Pôle de Psychiatrie, F-59000 Lille, France; Department of Neuroimaging, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK
8 shared publicationsThomas Fovet
Centre Lille Neuroscience & Cognition (INTERACTIONS), Univ. Lille, INSERM U1172, CHU Lille, Lille, France
7 shared publicationsAlexandre Dumais
Université de Montréal, institut Philippe-Pinel de Montréal, institut universitaire en santé mentale de Montréal, Montréal, Canada
4 shared publicationsFabien D'HOndt
Univ. Lille, INSERM U1172, CHU Lille, Centre Lille Neuroscience & Cognition (INTERACTIONS), F-59000 Lille, France; Centre National de Ressources et de Résilience Lille-Paris (CN2R), Lille F-59000, France
4 shared publicationsMarielle Wathelet
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; CHU Lille, Pôle de Psychiatrie, F-59000 Lille, France; Centre National de Ressources et de Résilience Lille-Paris (CN2R), Lille F-59000, France
4 shared publications
Latest Publications
- 6 September 2025
- Published by Elsevier in L'Encéphale
- Vol. 52 (1) , 101-103
L’universitarisation des territoires en psychiatrie – faciliter l’accès aux soins, lutter contre la désertification médicale
- 6 September 2025
- Published by Elsevier in L'Encéphale
- Vol. 52 (1) , 101-103
L’universitarisation des territoires en psychiatrie – faciliter l’accès aux soins, lutter contre la désertification médicale
- Open Access
- 26 May 2025
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 1-5
Can somatic symptom disorder be an iatrogenic disease?
Somatic Symptom Disorder (SSD) is defined as persistent and clinically significant somatic symptoms accompanied by excessive and inappropriate health-related thoughts, feelings and behaviours. The causes of SSD are not fully understood, but the biopsychosocial model posits that they result from vulnerability to both precipitating and maintaining factors that contribute to the progression of symptoms from short-term/acute distress presentation to a more persistent and even disabling problem. We report the case of a patient who developed a SSD after a prolonged period of medical care that ultimately led to the diagnosis of pheochromocytoma. After surgery (that should have resolved the initially-presenting problem), both physical symptoms and distress persisted, suggesting that SSD was present and remained even after treatment of the original/underlying physical symptom profile. This case report emphasizes the importance of early diagnosis of SSD when a patient presents with excessive health-related thoughts or behaviors, and not only after physical diagnoses have been ruled out. Based on the predictive model of SSD, early SSD treatment may help to reduce physical symptoms, regardless of their etiology. Diagnosing SSD and investigating the potential etiology of physical symptoms should be seen as complementary approaches, rather than opposing ones.
- 26 May 2025
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 1-5
Open AccessCan somatic symptom disorder be an iatrogenic disease?
Somatic Symptom Disorder (SSD) is defined as persistent and clinically significant somatic symptoms accompanied by excessive and inappropriate health-related thoughts, feelings and behaviours. The causes of SSD are not fully understood, but the biopsychosocial model posits that they result from vulnerability to both precipitating and maintaining factors that contribute to the progression of symptoms from short-term/acute distress presentation to a more persistent and even disabling problem. We report the case of a patient who developed a SSD after a prolonged period of medical care that ultimately led to the diagnosis of pheochromocytoma. After surgery (that should have resolved the initially-presenting problem), both physical symptoms and distress persisted, suggesting that SSD was present and remained even after treatment of the original/underlying physical symptom profile. This case report emphasizes the importance of early diagnosis of SSD when a patient presents with excessive health-related thoughts or behaviors, and not only after physical diagnoses have been ruled out. Based on the predictive model of SSD, early SSD treatment may help to reduce physical symptoms, regardless of their etiology. Diagnosing SSD and investigating the potential etiology of physical symptoms should be seen as complementary approaches, rather than opposing ones.
- 25 January 2023
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 166, 111172
Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder
- 25 January 2023
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 166, 111172
Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder
- 10 December 2021
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 30 (6) , 740-742
Prevalence and Risk Factors of PTSD in Older Survivors of Covid-19 Are The Elderly so Vulnerable?
- 10 December 2021
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 30 (6) , 740-742
Prevalence and Risk Factors of PTSD in Older Survivors of Covid-19 Are The Elderly so Vulnerable?
- 1 September 2021
- Published by Elsevier in General Hospital Psychiatry
- Vol. 72, 143-144
Psychological impact of the COVID-19 pandemic on non-frontline healthcare workers
- 1 September 2021
- Published by Elsevier in General Hospital Psychiatry
- Vol. 72, 143-144
Psychological impact of the COVID-19 pandemic on non-frontline healthcare workers
- 8 December 2020
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 82 (1)
Is COVID-19 Associated With Posttraumatic Stress Disorder?
To assess the prevalence of and risk factors for posttraumatic stress disorder (PTSD) in patients with COVID-19. We conducted a cohort study between March and May 2020 at the Lille University Hospital (France), including all patients with laboratory-confirmed COVID-19. Psychological distress symptoms were measured 3 weeks after onset of COVID-19 symptoms using the Impact of Event Scale-6 items (IES-6). The evaluation of PTSD symptoms using the PTSD Checklist for DSM-5 (PCL-5) took place 1 month later. Bivariate analyses were performed to analyze the relationship between PCL-5 scores and the demographic and health variables. The significant variables were then introduced into a multivariable linear regression analysis to establish their relative contributions to the severity of PTSD symptoms. 180 patients were included in this study, and 138 patients completed the 2 evaluations. Among the 180 patients, 70.4% patients required hospitalization, and 30.7% were admitted to the intensive care unit. The prevalence of PTSD was 6.5%, and the predictive factors of PTSD included psychological distress at the onset of the illness and a stay in an intensive care unit. The prevalence of PTSD in patients with COVID-19 is not as high as that reported among patients during previous epidemics. Initial psychological responses were predictive of a PTSD diagnosis, even though most patients showing acute psychological distress (33.5% of the sample) improved in the following weeks. PTSD symptoms also increased following a stay in an intensive care unit. Future studies should assess the long-term consequences of COVID-19 on patients' mental health.
- 8 December 2020
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 82 (1)
Is COVID-19 Associated With Posttraumatic Stress Disorder?
To assess the prevalence of and risk factors for posttraumatic stress disorder (PTSD) in patients with COVID-19. We conducted a cohort study between March and May 2020 at the Lille University Hospital (France), including all patients with laboratory-confirmed COVID-19. Psychological distress symptoms were measured 3 weeks after onset of COVID-19 symptoms using the Impact of Event Scale-6 items (IES-6). The evaluation of PTSD symptoms using the PTSD Checklist for DSM-5 (PCL-5) took place 1 month later. Bivariate analyses were performed to analyze the relationship between PCL-5 scores and the demographic and health variables. The significant variables were then introduced into a multivariable linear regression analysis to establish their relative contributions to the severity of PTSD symptoms. 180 patients were included in this study, and 138 patients completed the 2 evaluations. Among the 180 patients, 70.4% patients required hospitalization, and 30.7% were admitted to the intensive care unit. The prevalence of PTSD was 6.5%, and the predictive factors of PTSD included psychological distress at the onset of the illness and a stay in an intensive care unit. The prevalence of PTSD in patients with COVID-19 is not as high as that reported among patients during previous epidemics. Initial psychological responses were predictive of a PTSD diagnosis, even though most patients showing acute psychological distress (33.5% of the sample) improved in the following weeks. PTSD symptoms also increased following a stay in an intensive care unit. Future studies should assess the long-term consequences of COVID-19 on patients' mental health.
- 1 October 2020
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 137, 110214
Role and importance of consultation-liaison psychiatry during the Covid-19 epidemic
- 1 October 2020
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 137, 110214
Role and importance of consultation-liaison psychiatry during the Covid-19 epidemic
- 21 July 2020
- Published by Elsevier in Journal of Affective Disorders
- Vol. 276, 877-882
Emotional response in depersonalization: A systematic review of electrodermal activity studies
- 21 July 2020
- Published by Elsevier in Journal of Affective Disorders
- Vol. 276, 877-882
Emotional response in depersonalization: A systematic review of electrodermal activity studies
- 1 December 2019
- Published by Elsevier in L'Encéphale
- Vol. 45 (6) , 522-524
Soins psychiatriques sans consentement : une enquête auprès des juges des libertés et de la détention
- 1 December 2019
- Published by Elsevier in L'Encéphale
- Vol. 45 (6) , 522-524
Soins psychiatriques sans consentement : une enquête auprès des juges des libertés et de la détention